Access this stock data via API
Subscribe
Teva Pharmaceutical Industries Ltd. ADR
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.8B 3.6B 3.3B 3.6B
Cost of revenue 1.9B 1.8B 1.7B 1.8B
Gross profit 2.0B 1.8B 1.6B 1.8B
Operating expense
Research & development 218.1M 207.8M 210.4M 210.4M
Selling general and admin 828.8M 816.8M 782.8M 810.9M
Other operating expenses 4.3M
Operating income 915.6M 765.7M 601.3M 785.3M
Non operating interest income
Income
Expense 178.0M 172.9M 191.6M 203.6M
Other income expense -165.2M -378.2M -158.4M -751.3M
Pretax income 550.2M 172.9M 250.4M -210.4M
Tax provision 182.3M -66.4M 63.0M 23.8M
Net income 369.7M 241.0M 187.4M -234.2M
Basic EPS 0.3 0.2 -0.2
Diluted EPS 0.2 0.2 -0.2
Basic average shares 977.0M 987.2M 965.0M
Diluted average shares 988.9M 987.2M 965.0M
EBITDA 1.1B 933.5M 810.0M 948.9M
Net income from continuing op. 369.7M 241.0M 187.4M -234.2M
Minority interests -851.8K -5.1M 49.4M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 28 minutes

06:31
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).